Merit Medical Systems Inc
NASDAQ:MMSI
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
65.53
105.33
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Merit Medical Systems Inc
Merit Medical Systems Inc
Cash Equivalents
Merit Medical Systems Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Cash Equivalents
$523.1m
|
CAGR 3-Years
97%
|
CAGR 5-Years
70%
|
CAGR 10-Years
55%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Cash Equivalents
$299.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
22%
|
CAGR 10-Years
9%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash Equivalents
$296m
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Cash Equivalents
$312.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash Equivalents
$1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
16%
|
CAGR 10-Years
19%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash Equivalents
$866.4m
|
CAGR 3-Years
112%
|
CAGR 5-Years
62%
|
CAGR 10-Years
41%
|
|
Merit Medical Systems Inc
Glance View
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 6,446 full-time employees. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.
See Also
What is Merit Medical Systems Inc's Cash Equivalents?
Cash Equivalents
523.1m
USD
Based on the financial report for Sep 30, 2024, Merit Medical Systems Inc's Cash Equivalents amounts to 523.1m USD.
What is Merit Medical Systems Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
55%
Over the last year, the Cash Equivalents growth was 791%. The average annual Cash Equivalents growth rates for Merit Medical Systems Inc have been 97% over the past three years , 70% over the past five years , and 55% over the past ten years .
You don't have any saved screeners yet
